Scarica l'app Stockscreener
2.87
6.51%
-0.20
Quanterix Corp Borsa (QTRX) Ultime notizie
For Q3 board service, Quanterix (QTRX) grants director Donnelly 6,964 shares instead of cash. - stocktitan.net
A director converts awards into 4,224 shares at Quanterix (QTRX), bringing her holdings to 15,883 shares. - stocktitan.net
A 4,398-share grant replaces Q3 cash fees for Quanterix (QTRX) director Scott Mendel. - stocktitan.net
Global Alzheimer’s Disease Biomarker Market Poised for Phenomenal Expansion at a Growth Rate of ~9% by 2034 | DelveInsight - GlobeNewswire Inc.
Quanterix (QTRX) awards its CCO 260K RSUs - Stock Titan
365,326 stock units go to two new employees at Quanterix. They vest over four years. - Stock Titan
Quanterix (QTRX) CTO converts RSUs, withholds shares for taxes - Stock Titan
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Global Multiplex Assays Market 2026 Edition Consumables Dominate Multiplex Assays with 68% Market Share - GlobeNewswire Inc.
Quanterix (NASDAQ: QTRX) CTO uses shares to cover exercise price or taxes - Stock Titan
Bruker Corporation Executive is Named Finance Chief at Quanterix - Medical Product Outsourcing
Quanterix (QTRX) director adds 3,955 shares via RSU vest - Stock Titan
Quest Diagnostics Executive Recruited to Quanterix’s Senior Management Team - Medical Product Outsourcing
Quanterix (QTRX) CCO files initial ownership report with no shares - Stock Titan
Quanterix (QTRX) director now holds 162,401 shares - Stock Titan
Quanterix (QTRX) CTO converts RSUs, withholds shares for taxes - Stock Titan
Quanterix (QTRX) Q2 2026 Earnings Call Transcript - The Globe and Mail
QTRX Maintains Rating by Canaccord Genuity -- Price Target Lowered to $3.00 - GuruFocus
Quanterix (NASDAQ:QTRX) Price Target Cut to $3.00 by Analysts at Canaccord Genuity Group - MarketBeat
Canaccord cuts Quanterix stock price target on weak Q2 results - Investing.com
Canaccord cuts Quanterix stock price target on weak Q2 results - Investing.com
GSA Capital Partners LLP Makes New Investment in Quanterix Corporation $QTRX - MarketBeat
Quanterix Reshapes Sales Strategy, Targets Q4 FDA Decision for Alzheimer’s Blood Test - sharewise.com
Quanterix Reshapes Sales Strategy, Targets Q4 FDA Decision for Alzheimer’s Blood Test - sharewise.com
Quanterix Reshapes Sales Strategy, Targets Q4 FDA Decision for Alzheimer’s Blood Test - MarketBeat
Quanterix Reshapes Sales Strategy, Targets Q4 FDA Decision for Alzheimer’s Blood Test - Yahoo Finance
Quanterix (NASDAQ:QTRX) Lowered to Sell Rating by Wall Street Zen - MarketBeat
Quanterix Stock Price Forecast. Should You Buy QTRX? - StockInvest.us
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Quanterix Corp (QTRX) director-linked trusts buy 99,400 shares in open market - Stock Titan
Quanterix Corp (QTRX) Stock News Today - TradingKey
Quanterix Corp (QTRX) Stock News Today - TradingKey
Quanterix Corp (QTRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Quanterix at canaccord growth conference: sales reset aims to lift growth - Investing.com
Quanterix (QTRX) Earnings Shake Up The Story As Fair Value Still Sits Higher - Yahoo Finance
QTRX Maintains Hold Rating -- Price Target Lowered to $3.00 by T - GuruFocus
TD Cowen Issues Pessimistic Forecast for Quanterix (NASDAQ:QTRX) Stock Price - MarketBeat
Quanterix earnings missed by $0.64, revenue fell short of estimates - Investing.com Canada
Quanterix Corp (QTRX) (Q2 2026) Earnings Call Highlights: Revenue Miss and Guidance Cut Amid Market Softness - GuruFocus
Earnings call transcript: Quanterix Q2 2026 revenue miss sends shares down 43% - Investing.com South Africa
Quanterix Corp (QTRX) (Q2 2026) Earnings Call Highlights: Revenue Miss and Guidance Cut Amid ... - Yahoo Finance
Quanterix (NASDAQ:QTRX) Drops 39% After Outlook Revision Pushes Breakeven Back to 2027 - TechStock²
Quanterix Q2 Earnings Call Highlights - MarketBeat
Quanterix Cuts 2026 Revenue Outlook as Commercial Challenges Delay Cash-Flow Break-Even - Yahoo Finance
Quanterix earnings missed by $0.64, revenue fell short of estimates - Investing.com
Earnings call transcript: Quanterix Q2 2026 revenue miss sends shares down 43% - Investing.com Nigeria
Quanterix Q2 2026 slides: revenue miss prompts guidance cut - Investing.com
Earnings call transcript: Quanterix Q2 2026 revenue miss sends shares down 43% - Investing.com
Quanterix Corp (QTRX) Misses Q2 Earnings Estimates with EPS at - GuruFocus
Quanterix appoints Jim Gute as chief commercial officer - Investing.com
0.00%
3.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):